Longitudinal blood biomarker trajectories in preclinical Alzheimer's disease.

Yara YakoubNicholas J AshtonCherie Strikwerda-BrownLaia Montoliu-GayaThomas K KarikariPrzemysław R KacFernando Gonzalez-OrtizJonathan Gallego-RudolfPierre-François MeyerFrédéric St-OngeMichael SchöllJean-Paul SoucyJohn C S BreitnerHenrik ZetterbergKaj BlennowJudes PoirierSylvia Villeneuvenull null

Published in: Alzheimer's & dementia : the journal of the Alzheimer's Association (2023)

and pTau231 values are already abnormal at baseline in individuals with both amyloid and tau PET burden.

Keyphrases

depressive symptoms
computed tomography
cognitive decline
cerebrospinal fluid
pet ct
positron emission tomography
cross sectional
cell therapy
pet imaging
risk factors
stem cells
bone marrow